S Dauchy,S Dolbeault,M Reich
S Dauchy
Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors [0.03%]
血管内皮生长因子(VEGF)抑制剂的毒性反应及其管理措施的理解与应用
Manuela Schmidinger
Manuela Schmidinger
Bernard Escudier
Bernard Escudier
Rosalie Fisher,James Larkin
Rosalie Fisher
The seventh tumour-node-metastasis staging system for lung cancer: Sequel or prequel? [0.03%]
肺癌第七版肿瘤-淋巴结-远处转移分期系统：续集还是前传？
Jan P van Meerbeeck,Annelies Janssens
Jan P van Meerbeeck
Anatomical cancer extent is an important predictor of prognosis and determines treatment choices. In non-small-cell lung cancer (NSCLC) the tumour-node-metastasis (TNM) classification developed by Pierre Denoix replaced in 1968 the Veterans...
Keith M Kerr,Marianne C Nicolson
Keith M Kerr
Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer [0.03%]
可切除的非小细胞肺癌患者的辅助放疗疗效评价及其作用机制研究
Cecile Le Péchoux,Olaf Mercier,Deborah Belemsagha et al.
Cecile Le Péchoux et al.
Most long-term survivors of non-small-cell lung cancer (NSCLC) are patients who have had a completely resected tumour. However, this is only achievable in about 30% of the patients. Even in this highly selected group of patients, there is s...
Paul E Van Schil,Bram Balduyck,Michèle De Waele et al.
Paul E Van Schil et al.
Surgical resection remains the standard of care for functionally operable early-stage non-small-cell lung cancer (NSCLC) and resectable stage IIIA disease. The role of invasive staging and restaging techniques is currently being debated, bu...